Fresenius Medical Care AG earnings per share and revenue
On Nov 04, 2025, FMS reported earnings of 1.10 USD per share (EPS) for Q3 25, beating the estimate of 0.96 USD, resulting in a 14.17% surprise. Revenue reached 4.88 billion, compared to an expected 4.97 billion, with a -1.72% difference. The market reacted with a -7.82% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of 0.92 USD, with revenue projected to reach 4.88 billion USD, implying an decrease of -16.36% EPS, and decrease of -0.18% in Revenue from the last quarter.
FAQ
What were Fresenius Medical Care AG's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Fresenius Medical Care AG reported EPS of $1.10, beating estimates by 14.17%, and revenue of $4.88B, -1.72% below expectations.
How did the market react to Fresenius Medical Care AG's Q3 2025 earnings?
The stock price moved down -7.82%, changed from $26.35 before the earnings release to $24.29 the day after.
When is Fresenius Medical Care AG expected to report next?
The next earning report is scheduled for Feb 24, 2026.
What are the forecasts for Fresenius Medical Care AG's next earnings report?
Based on 8
analysts, Fresenius Medical Care AG is expected to report EPS of $0.92 and revenue of $4.88B for Q4 2025.